The global Cell Isolation/Cell SeparationMarketwas valued at USD 3.53 billion in 2016 and is projected to reach USD 14.64 billion by 2025, growing at a CAGR of 17.12% from 2017 to 2025.
Isolation of one or multiple cell types from a heterogeneous population is an integral part of modern biological research and routine clinical diagnosis and treatment. Purification of specific cells is essential for basic cell biology research, cellular enumeration in certain pathologies and cell based studies.
Sample Infographics:
Market Dynamics:
1. Market Drivers
1.1 Growing availability of fund from Govt. Sector
1.2 Rising cases of Cancer
1.3 Technological developments
1.4 Growing focus on personalized medicine
1.5 Expanding Biotech and Biopharmaceutical Sector
2. Market Restraints
2.1 High Cost of Isolation Instruments
2.2 Ethical restraints
Market Segmentation:
1. Global Cell Isolation/Cell Separation Market, by End User:
1.1 Research Laboratories and Institutes
1.2 Hospitals and Diagnostic Laboratories
1.3 Cell Banks
1.4 Biotechnology and Biopharmaceutical Companies
2. Global Cell Isolation/Cell Separation Market, by Application:
2.1 Biomolecule Isolation
2.2 Cancer Research
2.3 Stem Cell Research
2.4 Tissue Regeneration
2.5 In Vitro Diagnostics
2.6 Therapeutics
3. Global Cell Isolation/Cell Separation Market, by Technique:
3.1 Centrifugation-Based Cell Isolation
3.2 Surface Marker-Based Cell Isolation
3.3 Filtration-Based Cell Isolation
4. Global Cell Isolation/Cell Separation Market, by Cell Type:
4.1 Human Cells
4.1.1 Differentiated Cells
4.1.2 Stem Cells
4.2 Animal Cells
5. Global Cell Isolation/Cell Separation Market, by Product:
5.1 Consumables
5.1.1 Reagents, Kits, Media, and Sera
5.1.2 Beads
5.1.3 Disposables
5.2 Instruments
5.2.1 Centrifuges
5.2.2 Flow Cytometers
5.2.3 Magnetic-Activated Cell Separator Systems
6. Global Cell Isolation/Cell Separation Market, by Region:
6.1 North America (U.S., Canada, Mexico)
6.2 Europe (Germany, UK, France, Rest of Europe)
6.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
6.4 Latin America (Brazil, Argentina, Rest of Latin America)
6.5 Middle East & Africa
Competitive Landscape:
The major players in the market are as follows:
1. Beckman Coulter (Subsidiary of Danaher Corporation)
2. Becton, Dickinson and Company
3. GE Healthcare (A Fully Owned Subsidiary of General Electric Company)
4. Merck KGaA
5. Thermo Fisher Scientific Inc.
6. MiltenyiBiotec
7. Pluriselect Life Science
8. Stemcell Technologies Inc.
9. Terumo Bct (A Subsidiary of Terumo Corporation)
10. Bio-Rad Laboratories, Inc.
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.
RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the Cell Isolation/Cell SeparationMarketwas performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.
To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.
1 INTRODUCTION OF GLOBAL CELL ISOLATION/CELL SEPARATIONMARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources
4 GLOBAL CELL ISOLATION/CELL SEPARATIONMARKETOUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework
5 GLOBAL CELL ISOLATION/CELL SEPARATION MARKET, BY END USER
5.1 Research Laboratories and Institutes
5.2 Hospitals and Diagnostic Laboratories
5.3 Cell Banks
5.4 Biotechnology and Biopharmaceutical Companies
6 GLOBAL CELL ISOLATION/CELL SEPARATION MARKET, BY APPLICATION
6.1 Biomolecule Isolation
6.2 Cancer Research
6.3 Stem Cell Research
6.4 Tissue Regeneration
6.5 In Vitro Diagnostics
6.6 Therapeutics
7 GLOBAL CELL ISOLATION/CELL SEPARATION MARKET, BY TECHNIQUE
7.1 Centrifugation-Based Cell Isolation
7.2 Surface Marker-Based Cell Isolation
7.3 Filtration-Based Cell Isolation
8 GLOBAL CELL ISOLATION/CELL SEPARATION MARKET, BY CELL TYPE
8.1 Human Cells
8.1.1 Differentiated Cells
8.1.2 Stem Cells
8.2 Animal Cells
9 GLOBAL CELL ISOLATION/CELL SEPARATION MARKET, BY PRODUCT
9.1 Consumables
9.1.1 Reagents, Kits, Media, and Sera
9.1.2 Beads
9.1.3 Disposables
9.2 Instruments
9.2.1 Centrifuges
9.2.2 Flow Cytometers
9.2.3 Magnetic-Activated Cell Separator Systems
10 GLOBAL CELL ISOLATION/CELL SEPARATIONMARKET, BY GEOGRAPHY
10.1 Overview
10.2 North AmericaRegional Market Estimates and Forecasts, 2012 - 2025
10.2.1 U.S.
10.2.2 Canada
10.2.3 Mexico
10.3 EuropeRegional Market Estimates and Forecasts, 2012 - 2025
10.3.1 Germany
10.3.2 U.K.
10.3.3 France
10.3.4 Rest of Europe
10.4 Asia PacificRegional Market Estimates and Forecasts, 2012 - 2025
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Rest of Asia Pacific
10.5 Latin AmericaRegional Market Estimates and Forecasts, 2012 - 2025
10.5.1 Brazil
10.5.2 Argentina
10.6 Rest of the WorldRegional Market Estimates and Forecasts, 2012 - 2025
11 GLOBAL CELL ISOLATION/CELL SEPARATIONMARKETCOMPETITIVE LANDSCAPE
11.1 Overview
11.2 Company Market Share
11.3 Vendor Landscape
11.4 Key Development Strategies
12 COMPANY PROFILES
12.1 Beckman Coulter (Subsidiary of Danaher Corporation)
12.1.1 Overview
12.1.2 Financial Performance
12.1.3 Product Outlook
12.1.4 Key Developments
12.2 Becton, Dickinson and Company
12.2.1 Overview
12.2.2 Financial Performance
12.2.3 Product Outlook
12.2.4 Key Developments
12.3 GE Healthcare (A Fully Owned Subsidiary of General Electric Company)
12.3.1 Overview
12.3.2 Financial Performance
12.3.3 Product Outlook
12.3.4 Key Developments
12.4 Merck KGaA
12.4.1 Overview
12.4.2 Financial Performance
12.4.3 Product Outlook
12.4.4 Key Developments
12.5 Thermo Fisher Scientific Inc.
12.5.1 Overview
12.5.2 Financial Performance
12.5.3 Product Outlook
12.5.4 Key Developments
12.6 MiltenyiBiotec
12.6.1 Overview
12.6.2 Financial Performance
12.6.3 Product Outlook
12.6.4 Key Developments
12.7 Pluriselect Life Science
12.7.1 Overview
12.7.2 Financial Performance
12.7.3 Product Outlook
12.7.4 Key Developments
12.8 Stemcell Technologies Inc.
12.8.1 Overview
12.8.2 Financial Performance
12.8.3 Product Outlook
12.8.4 Key Developments
12.9 Terumo Bct (A Subsidiary of Terumo Corporation)
12.9.1 Overview
12.9.2 Financial Performance
12.9.3 Product Outlook
12.9.4 Key Developments
12.10 Bio-Rad Laboratories, Inc.
12.10.1 Overview
12.10.2 Financial Performance
12.10.3 Product Outlook
12.10.4 Key Developments
13 Appendix
13.1 Related Reports
Price : US$ 3500 |
Date : Dec 2024 |
Category : Electronics |
Pages : 233 |